Evaluation of soft tissue and crestal bone changes around non submerged platform switch implants placed epicrestal and subcrestal
Phase 2
- Conditions
- Health Condition 1: K069- Disorder of gingiva and edentulousalveolar ridge, unspecified
- Registration Number
- CTRI/2021/07/034797
- Lead Sponsor
- chennu swetha
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Closed to Recruitment of Participants
- Sex
- Not specified
- Target Recruitment
- 28
Inclusion Criteria
1.Apparently healthy individuals.
2.Patients with thin gingival biotype (<=2mm).
3.Individuals with adequate bone quality (D2 or D3 type) and volume.
4. Presence of adequate keratinized tissue at the edentulous site.
5.Patients who are willing to give informed consent.
Exclusion Criteria
1.Smokers.
2.Individuals with parafunctional habits.
3.Pregnant and lactating women.
4.Patients taking any medication or drug that could jeopardize treatment outcome.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To evaluate soft tissue and crestal bone changes around epicrestally placed non-submerged platform switch implants.2.To evaluate soft tissue and crestal bone changes around sub-crestally placed non-submerged platform switch implants.Timepoint: baseline,3 months,6 months
- Secondary Outcome Measures
Name Time Method 3.To compare soft tissue and crestal bone changes between epicrestally and subcrestally placed non submerged platform switch implants.Timepoint: baseline,3months,6 months